0001209191-22-025160.txt : 20220421 0001209191-22-025160.hdr.sgml : 20220421 20220421160509 ACCESSION NUMBER: 0001209191-22-025160 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220419 FILED AS OF DATE: 20220421 DATE AS OF CHANGE: 20220421 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Desai Veeral CENTRAL INDEX KEY: 0001855973 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40332 FILM NUMBER: 22841432 MAIL ADDRESS: STREET 1: C/O AGILON HEALTH, INC. STREET 2: 6210 E HWY 290, SUITE 450 CITY: AUSTIN STATE: TX ZIP: 78723 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: agilon health, inc. CENTRAL INDEX KEY: 0001831097 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MISC HEALTH & ALLIED SERVICES, NEC [8090] IRS NUMBER: 371915147 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 6210 E HWY 290 STREET 2: SUITE 450 CITY: AUSTIN STATE: TX ZIP: 78723 BUSINESS PHONE: 562-256-3800 MAIL ADDRESS: STREET 1: 6210 E HWY 290 STREET 2: SUITE 450 CITY: AUSTIN STATE: TX ZIP: 78723 FORMER COMPANY: FORMER CONFORMED NAME: Agilon Health Topco, Inc. DATE OF NAME CHANGE: 20201103 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-04-19 0 0001831097 agilon health, inc. AGL 0001855973 Desai Veeral C/O AGILON HEALTH, INC. 6210 E HWY 290, SUITE 450 AUSTIN TX 78723 0 1 0 0 Chief Strategy & Dev. Officer Common Stock 2022-04-19 4 M 0 106357 1.00 A 384568 D Common Stock 2022-04-19 4 S 0 106357 22.74 D 278211 D Common Stock 2022-04-20 4 M 0 106357 1.00 A 384568 D Common Stock 2022-04-20 4 S 0 106357 22.34 D 278211 D Options (Rights to Buy) 1.00 2022-04-19 4 M 0 106357 0.00 D 2027-04-27 Common Stock 106357 775351 D Options (Rights to Buy) 1.00 2022-04-20 4 M 0 106357 0.00 D 2027-04-27 Common Stock 106357 668994 D Includes restricted stock units. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $21.90 to $23.05, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $21.76 to $22.93, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. These options were granted on April 27, 2017 and fully vested on April 27, 2021. /s/ Lyn Amor Macaraeg, as Attorney-in-Fact 2022-04-21